Richard A Colvin is Chief Medical Officer of bluebird bio, Inc.. Currently has a direct ownership of 118,368 shares of BLUE, which is worth approximately $62,735. The most recent transaction as insider was on Mar 01, 2024, when has been sold 6,770 shares (Common Stock) at a price of $1.53 per share, resulting in proceeds of $10,358. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K
0% 3M change
7.58% 12M change
Total Value Held $62,735

Richard A Colvin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2024
SELL
Open market or private sale
$10,358 $1.53 p/Share
6,770 Reduced 5.41%
118,368 Common Stock
Jan 05 2024
SELL
Open market or private sale
$847 $1.42 p/Share
597 Reduced 0.47%
125,138 Common Stock
Nov 02 2023
SELL
Open market or private sale
$6,982 $2.98 p/Share
2,343 Reduced 1.83%
125,735 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
55,000 Added 30.04%
128,078 Common Stock
Feb 01 2023
SELL
Payment of exercise price or tax liability
$7,356 $6.38 p/Share
1,153 Reduced 1.55%
73,078 Common Stock
Jan 11 2023
SELL
Open market or private sale
$4,344 $7.8 p/Share
557 Reduced 0.74%
74,231 Common Stock
Nov 04 2022
SELL
Open market or private sale
$1,397 $6.41 p/Share
218 Reduced 0.29%
74,788 Common Stock
Nov 01 2022
BUY
Grant, award, or other acquisition
-
30,000 Added 28.57%
75,006 Common Stock
RAC

Richard A Colvin

Chief Medical Officer
Somerville, MA

Track Institutional and Insider Activities on BLUE

Follow bluebird bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE